All attending UK organisations

UK companies attendingBio-Europe as part of the official delegation

(Click here to search profiles):

UK delegation:
BioPartner UK, Albumedix, Almac Discovery, Arctoris, Aspire Pharma, bit bio, Curileum, Fusion Antibodies, Isogenica, Karma Oncology, Mogrify, NIHR CRN, Oncimmune, Oppilotech, Quotient Sciences, Sekisui, Silence Therapeutics, SomaServe, UK BioIndustry Association.

Other UK companies associated with the delegation*:
C4X Discovery, Crystec, Diurnal Group, e-therapeutics, Evgen Pharma, George Medicines UK, HC Pharma Consultancy, Locust Walk, LSX, Mawdsleys, Microbiotica, ProImmune, RBW Consulting, SBA Ltd, Therakind, Vaccitech.

All attending UK companies:
4basebio, 4BIO Capital, 4D pharma, Abcam, Accord Healthcare, Actigen, Adaptate Biotherapeutics, ADM, Advanz Pharma, AlphaSense, Antiverse, APM Health Europe, Apple Tree Life Sciences (UK), Aptorum Group, Arecor, Asieris Pharmaceutical, Astellas Pharma, AstraZeneca, Avacta Life Science, Barrington James, BDD Pharma, Bicycle Therapeutics, BicycleTx, Biogen, Box, Brandon Capital Partners, Bristol Myers Squibb, Cancer Research UK, Charnwood Molecular, Chugai Pharmaceutical Co., Clarivate, Clinigen, CNX Therapeutics, Consilient Health, Cumulus Oncology, Daewoong Pharmaceuticals, Deep Science Ventures, Dentons UK Ireland and Middle East, Destiny Pharma, EBD Group, Edinburgh Innovations, Eisai Europe, Elanco Animal Health, Eli Lilly and Company, Ellipses Pharma, Enedra Therapeutics, Enterprise Therapeutics, Evaluate, Evox Therapeutics, Exvastat, F-star Therapeutics, Glamorous AI, GlobalData, GSK, Healx, Heptares Therapeutics, HungaroTrial CRO, ICON, Ikarovec, Immunocore, Imperial College London, Inceptua Early Access, Infinity-BiologiX, Informa Pharma Intelligence, Innovent Biologics (Europe), IN-PART, Intract Pharma, Jazz Pharmaceuticals, Johnson & Johnson Innovation, Kinomica, Kreos Capital, Kx Advisors, Kyowa Kirin Co., Labcorp Drug Development, LifeSci Advisors, Livzon Pharmaceutical Group, Lonza, Macrophage Pharma, MD Group, Medicines Discov Instit, Cardiff Univ, MEDICXI, MedPharm, Merck Group, Mereo BioPharma, MetalloBio, Midatech Pharma, Mission Therapeutics, Mitsubishi Tanabe Pharma, Monograph Capital Advisors, MSD, Mundipharma International, Nanomerics., Nanovery, Nature Research, Newcastle University, NOCRI, Norgine, Novai, Novitious, OBN UK, OncoBone Ventures, One Nucleus, Ono Pharmaceutical, Orbit Discovery, Otsuka Pharmaceuticals, Oxford Biotherapeutics, Oxford Brookes University, Oxyrane, Persica Pharmaceuticals, Pharmanovia, Pharmaron, PharmaVentures, PharmEnable, Phastar, PhoreMost, PrecisionLife, Premier Research, Proclinical, Proimmune, Prokarium, Quadram Institute Bioscience, QUB, Rallybio, Random42 Scientific Communication, Renata Limited (UK), Reneo Pharmaceuticals, Renovos Biologics, Results Healthcare, Rosemont Pharmaceuticals, Sage Healthcare, Samedan, Scius Communications, Selentus Science, Shanghai Medicilon, SHIONOGI, Simcere Pharmaceutical Group, SLA, Solomon Page, Sonrai Analytics, Standigm, SV Health Investors, Symbioses, Tanner Pharma, Teijin Pharma, The University of Sheffield, Torreya, tranScrip, Treehill Partners, UAB "GuruMA", Ubiquigent, Ulster University, University of Bradford, University of Bristol, University of Edinburgh, University of Glasgow, University of Huddersfield, University of York, ValiRx, Virdis Group, WuXi AppTec, WuXi Biologics, Wyoming Interactive. (162)

Join them here!